title: Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
abstract: The Dual Diagnosis Capability in Addiction Treatment and the Dual Diagnosis Capability in Mental Health Treatment indexes were used to document change in the capability of 14 substance abuse and mental health agencies to provide services to clients with co-occurring substance use and mental disorders (COD). COD capability significantly increased over 2 years, with the largest improvements seen in client assessment and staff training for COD. The role of agency structural characteristics and organizational readiness for change was also investigated. The study found modest evidence that some structural characteristics (e.g., agency size) and organizational readiness for change were related to increased COD capability. Further study is needed of how these factors affect implementation and fidelity to evidence-based practices, including how programs might compensate for or modify the effects of organizational factors to enhance implementation efforts.
authors.affiliation: Mid-America Addiction Technology Transfer Center, University of Missouri-Kansas City, Kansas City, MO 64110-2499, USA. gothamhj@umkc.edu
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Gotham
authors.forename: Ronald E
authors.initials: RE
authors.lastname: Claus
authors.forename: Kim
authors.initials: K
authors.lastname: Selig
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Homer
mesh_terms: D003156:Community Mental Health Services / Q000458:organization & administration*; D019033:Delivery of Health Care, Integrated; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006301:Health Services Needs and Demand; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D016730:Program Development; D016320:Substance Abuse Treatment Centers / Q000458:organization & administration*; D019966:Substance-Related Disorders / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome